Search research articles
Contact Us
Filters
Showing results (161-170 of 263) with videos related to
Page
of 27
Sort By:
Clinical Pharmacology and Therapeutics
|
June 1, 1995
Phenotyping and genotyping of S-mephenytoin hydroxylase (cytochrome P450 2C19) in a Shona population of Zimbabwe
C Masimirembwa, L Bertilsson, I Johansson, et al.
Pharmacology
|
January 1, 1979
Intraindividual similarity in the metabolism of amitriptyline and chlorimipramine in depressed patients
B Mellström, L Bertilsson, L Träskman, et al.
European Journal of Clinical Pharmacology
|
November 1, 1980
Monoamine metabolites in cerebrospinal fluid during treatment of hypertension with prazosin
P Seideman, L Bertilsson, K Haglund, et al.
Nordisk Psykiatrisk Tidsskrift. Nordic Journal of Psychiatry
|
January 1, 1972
[Studies of indolamine metabolites in cerebrospinal fluid in depression]
M Asberg, L Bertilsson, B Cronholm, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1995
Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis
M L Dahl, I Johansson, L Bertilsson, et al.
Acta Psychiatrica Scandinavica
|
January 1, 1993
Relationship between personality and debrisoquine hydroxylation capacity. Suggestion of an endogenous neuroactive substrate or product of the cytochrome P4502D6
A Llerena, G Edman, J Cobaleda, et al.
Therapeutic Drug Monitoring
|
October 1, 1995
Enantioselective determination of mianserin and its desmethyl metabolite in plasma during treatment of depressed Japanese patients
G Tybring, K Otani, S Kaneko, et al.
Archives of Neurology
|
August 1, 1990
Carbamazepine-10,11-epoxide in epilepsy. A pilot study
T Tomson, O Almkvist, B Y Nilsson, et al.
Clinical Pharmacology and Therapeutics
|
November 1, 1990
Diazepam metabolism in native Chinese poor and extensive hydroxylators of S-mephenytoin: interethnic differences in comparison with white subjects
Y A Zhang, J Reviriego, Y Q Lou, et al.
Pharmacological Research
|
January 1, 1989
Effects of valpromide and viloxazine on the elimination of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine
E Perucca, F Pisani, E Spina, et al.
Page
of 27
Search research articles
Search
Showing results (161-170 of 263) with videos related to
Sort By:
Page
of 27
Clinical Pharmacology and Therapeutics
|
June 1, 1995
Phenotyping and genotyping of S-mephenytoin hydroxylase (cytochrome P450 2C19) in a Shona population of Zimbabwe
C Masimirembwa, L Bertilsson, I Johansson, et al.
Pharmacology
|
January 1, 1979
Intraindividual similarity in the metabolism of amitriptyline and chlorimipramine in depressed patients
B Mellström, L Bertilsson, L Träskman, et al.
European Journal of Clinical Pharmacology
|
November 1, 1980
Monoamine metabolites in cerebrospinal fluid during treatment of hypertension with prazosin
P Seideman, L Bertilsson, K Haglund, et al.
Nordisk Psykiatrisk Tidsskrift. Nordic Journal of Psychiatry
|
January 1, 1972
[Studies of indolamine metabolites in cerebrospinal fluid in depression]
M Asberg, L Bertilsson, B Cronholm, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1995
Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis
M L Dahl, I Johansson, L Bertilsson, et al.
Acta Psychiatrica Scandinavica
|
January 1, 1993
Relationship between personality and debrisoquine hydroxylation capacity. Suggestion of an endogenous neuroactive substrate or product of the cytochrome P4502D6
A Llerena, G Edman, J Cobaleda, et al.
Therapeutic Drug Monitoring
|
October 1, 1995
Enantioselective determination of mianserin and its desmethyl metabolite in plasma during treatment of depressed Japanese patients
G Tybring, K Otani, S Kaneko, et al.
Archives of Neurology
|
August 1, 1990
Carbamazepine-10,11-epoxide in epilepsy. A pilot study
T Tomson, O Almkvist, B Y Nilsson, et al.
Clinical Pharmacology and Therapeutics
|
November 1, 1990
Diazepam metabolism in native Chinese poor and extensive hydroxylators of S-mephenytoin: interethnic differences in comparison with white subjects
Y A Zhang, J Reviriego, Y Q Lou, et al.
Pharmacological Research
|
January 1, 1989
Effects of valpromide and viloxazine on the elimination of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine
E Perucca, F Pisani, E Spina, et al.
Page
of 27